CNIPA.AI

Company patentsCompare

HEAD TO HEAD

China Construction BankEli LillyMeta

Technology portfolios compared in the same window and counting units. Scale is compared only within the same field or subclass.

Same window · published 2025-01-01 — 2025-12-31Some name or date coverage is incomplete; affected counts are lower bounds

This is a structural comparison of collected portfolios. The same requested window does not establish equal entity scope, covered months or industry; no competitive ranking is inferred.

Applicant-name coverage differs. The counts below cover only the listed names and do not represent complete company portfolios.

China Construction Bank: Applicant names included in these statistics — CHINA CONSTRUCTION BANK CORPReviewed names not covered — CHINA CONSTRUCTION BANK CORPORATION · 中国建设银行股份有限公司

Eli Lilly: Applicant names included in these statistics — ELI LILLY AND CO · ELI LILLY AND COMPANY USA · LILLY CO ELIReviewed names not covered — ELI LILLY AND COMPANY

Meta: Applicant names included in these statistics — FACEBOOK INC · META PLATFORMS INC · META PLATFORMS TECH LLCReviewed names not covered — FACEBOOK TECHNOLOGIES LLC · FACEBOOK, INC. · META PLATFORMS TECHNOLOGIES , LLC · META PLATFORMS TECHNOLOGIES LLC · META PLATFORMS TECHNOLOGIES, LLC · META PLATFORMS TECHNOLOGIES, LLC. · META PLATFORMS, INC. · OCULUS VR LLC

China Construction Bank

Publications
1,106
Invention share
100%
Concentration
0.72
Green technology
—

Eli Lilly

Publications
1,602
Invention share
45%
Concentration
0.73
Green technology
—

Meta

Publications
1,545
Invention share
97%
Concentration
0.43
Green technology
—
0.01

China Construction Bank × Eli Lilly

0.69

China Construction Bank × Meta

0.01

Eli Lilly × Meta

Cosine similarity of application counts across 35 fields. 1 is identical, 0 is no overlap.

01Technology field mirror

The 12 fields with the largest combined share. Share shows structure; count shows scale.

Technology field mirror
Technology fieldChina Construction Bank / Eli Lilly / Meta
Computer technology
72.3%
0.6%
49.3%
Pharmaceuticals
0%
68.5%
0%
IT methods for management
40.7%
0.2%
2.1%
Biotechnology
0%
39.9%
0%
Optics
0%
0%
36.7%
Digital communication
17.9%
0.1%
12.4%
Organic fine chemistry
0%
25.8%
0%
Medical technology
0.4%
17.6%
2.5%
Audio-visual technology
0.2%
0.1%
17%
Telecommunications
0.5%
0%
5.5%
Electrical machinery, apparatus, energy
0%
0%
5.4%
Measurement
0%
1%
4.1%

Inspect one technology field

Inspect collected applications, portfolio share and supporting publications within one field. A technology overlap does not establish that companies in different industries are direct competitors.

Meta

Collected applications
250
Share of collected applications with IPC
17%

Coverage is incomplete; counts and shares describe only the collected subset.

View Meta publications in this field

One application may belong to multiple fields, so shares can sum to more than 100%. Drill-down lists publications; an application publication and its grant may appear separately.

02Same problem: shared IPC subclasses

The 10 subclasses in every company's top 60 with the most combined applications. Scale is compared within a subclass, never across different business scopes.

G06FData processing
China Construction Bank764
Eli Lilly2
Meta541
G06QBusiness data processing
China Construction Bank450
Eli Lilly3
Meta31
G06TImage processing
China Construction Bank13
Eli Lilly5
Meta307
G06NComputing models, AI
China Construction Bank118
Eli Lilly3
Meta41
G06VImage and video recognition
China Construction Bank24
Eli Lilly2
Meta122
H04WWireless networks
China Construction Bank5
Eli Lilly2
Meta101
G16H
China Construction Bank4
Eli Lilly36
Meta4
G08B
China Construction Bank1
Eli Lilly5
Meta6

03Where each one leans

Observed emphasis within each company’s collected top-60 IPC subclasses. A dash for another company means outside its top-60 list, not zero applications or a market gap. Incomplete coverage can also change the ordering.

China Construction Bank

  • G06QBusiness data processing
    China Construction Bank
    450
    Eli Lilly
    3
    Meta
    31
  • G06FData processing
    China Construction Bank
    764
    Eli Lilly
    2
    Meta
    541
  • H04LDigital transmission
    China Construction Bank
    191
    Eli Lilly
    —
    Meta
    112
  • G06NComputing models, AI
    China Construction Bank
    118
    Eli Lilly
    3
    Meta
    41
  • G06K
    China Construction Bank
    2
    Eli Lilly
    —
    Meta
    —
  • G07C
    China Construction Bank
    2
    Eli Lilly
    —
    Meta
    —

Eli Lilly

  • A61K
    China Construction Bank
    —
    Eli Lilly
    926
    Meta
    —
  • A61P
    China Construction Bank
    —
    Eli Lilly
    766
    Meta
    —
  • C07K
    China Construction Bank
    —
    Eli Lilly
    454
    Meta
    —
  • C07DHeterocyclic compounds
    China Construction Bank
    —
    Eli Lilly
    300
    Meta
    —
  • A61M
    China Construction Bank
    —
    Eli Lilly
    196
    Meta
    —
  • C12NMicroorganisms, enzymes
    China Construction Bank
    —
    Eli Lilly
    153
    Meta
    —

Meta

  • G02BOptical elements
    China Construction Bank
    —
    Eli Lilly
    —
    Meta
    483
  • G06TImage processing
    China Construction Bank
    13
    Eli Lilly
    5
    Meta
    307
  • H04NPictorial communication, video
    China Construction Bank
    8
    Eli Lilly
    —
    Meta
    135
  • H04WWireless networks
    China Construction Bank
    5
    Eli Lilly
    2
    Meta
    101
  • G06VImage and video recognition
    China Construction Bank
    24
    Eli Lilly
    2
    Meta
    122
  • G02FOptical control devices
    China Construction Bank
    —
    Eli Lilly
    —
    Meta
    69

04Publication rhythm

China Construction BankEli LillyMetaPublications per period
Publications per period
PeriodChina Construction BankEli LillyMeta
2025-01≥199 (partial coverage)≥118 (partial coverage)≥116 (partial coverage)
2025-02≥228 (partial coverage)≥121 (partial coverage)≥146 (partial coverage)
2025-03≥163 (partial coverage)≥158 (partial coverage)≥163 (partial coverage)
2025-04≥52 (partial coverage)≥110 (partial coverage)≥153 (partial coverage)
2025-05≥15 (partial coverage)≥134 (partial coverage)≥142 (partial coverage)
2025-06≥16 (partial coverage)≥140 (partial coverage)≥124 (partial coverage)
2025-07≥22 (partial coverage)≥138 (partial coverage)≥123 (partial coverage)
2025-08≥16 (partial coverage)≥134 (partial coverage)≥130 (partial coverage)
2025-09≥10 (partial coverage)≥132 (partial coverage)≥94 (partial coverage)
2025-10≥11 (partial coverage)≥155 (partial coverage)≥153 (partial coverage)
2025-11≥67 (partial coverage)≥140 (partial coverage)≥102 (partial coverage)
2025-12≥307 (partial coverage)≥122 (partial coverage)≥99 (partial coverage)

Empty dashed outlines mark uncollected periods. Hatched bars and ≥ counts mark partial coverage.

Publication timing follows examination and publication cycles, not R&D intensity.

What makes it comparableThe same publication window and counting units. Companies with different windows are not put in one comparison.

What is not comparableGroup totals. Business and entity scopes differ; compare scale within a field or subclass.

Not a rankingSimilarity and shares describe structure, not patent value, quality or technical leadership.